Riskpilot← Back to searchSign inGet full accessDocmer Oy
OYDissolvedY-tunnus 2462745-7Eiranranta 7Medical specialists activities · NACE 8622Est. 2012— employees
Revenue 2025
EUR 378K
-30% vs 2024
EBITDA margin
39.5%
-23% vs 2024
Equity ratio
98.6%
Financial strength
Net profit 2025
EUR 119K
-48% vs 2024
| Revenue | EUR 378K | -30% |
| EBITDA | EUR 149K | -23% |
| Net profit | EUR 119K | -48% |
| Total assets | EUR 799K | -2% |
| Equity | EUR 787K | +3% |
| Employees | — | — |
Legal name
Docmer Oy
Y-tunnus number
2462745-7
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
17. helmikuuta 2012
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Yhtiön toimiala on lääketieteelliset ja erikoislääkärin antamat palvelut, hoidot ja tutkimukset, terveydenhuollon koulutus ja konsultointipalvelut, henkilöstön vuokraus sosiaali- ja terveyspalveluissa sekä näihin liittyvissä tukipalveluissa, rekrytointipalvelut, hoitotarvikkeiden, instrumenttien ja itsehoitotuotteiden myynti, terveydenhuollon tietotekniikkasovellusten kehitys ja myynti, arvopaperikauppa sekä kiinteistöjen omistaminen ja vuokraus.
Address
Eiranranta 7
Phone
+3580504388518
Email
mervi.starck@fimnet.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 409 | 492 | 650 | 544 | 378 |
| Staff expenses | −156 | −157 | −177 | −141 | −83 |
| EBITDA | 117 | 169 | 258 | 193 | 149 |
| Depreciation & amort. | −4 | −5 | −5 | −4 | −4 |
| EBIT | 112 | 164 | 253 | 189 | 145 |
| Net financials | −1 | — | −0 | 91 | 4 |
| Profit before tax | 111 | 164 | 253 | 280 | 149 |
| Tax | 22 | 33 | −0 | 51 | −30 |
| Net profit | 89 | 131 | 202 | 229 | 119 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 433 | 522 | 680 | 813 | 799 |
| Equity | 377 | 448 | 614 | 767 | 787 |
| Long-term debt | — | — | 0 | 0 | — |
| Short-term debt | 57 | 74 | 66 | 45 | 11 |
| Total debt | 57 | 74 | 66 | 45 | 11 |
EBITDA margin
39.5%
This company
15.8%
Market median
+150% vs market
20212025
Equity ratio
98.6%
This company
38.2%
Market median
+158% vs market
20212025
Return on equity
15.1%
This company
18.4%
Market median
+18% vs market
20212025
Net profit margin
31.4%
This company
8.1%
Market median
+288% vs market
20212025
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
MH Chief Executive Officer | Chief Executive Officer | 2012 |
RE Deputy Member | Deputy Member | 2012 |
EI Deputy Member | Deputy Member | 2020 |
JA | Audit | 2023 |
PR Deputy auditor | Deputy auditor | 2023 |
| Former (1) | ||
AO | Audit | 2020 – 2023 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Docmer Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mervi Helena Starck | Chief Executive Officer | 0 companies |
| Reetta Elli Aurora Nevakivi | Deputy Member | 0 companies |
| Erika Ida Katarina Mäkelä | Deputy Member | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Aarto Ossi Juhani Hirvi | Audit | 0 companies |
| Petteri Raine Lagus | Deputy auditor | 0 companies |